Table 1 Characterization of MCL patients
From: A novel vaccine for mantle cell lymphoma based on targeting cyclin D1 to dendritic cells via CD40
Patient ID number | Age | Gender | Prior Treatment | Ongoing Treatment | Disease Stage | HLA type |
|---|---|---|---|---|---|---|
1. ACC-2000, ACC-2003a | 69 | M | T, Chemo | - | Remission | A*0201B*1501*3503C*0303*1203 DRB1*0401*1401 DQB1*0503*0302 |
2. ACC-2038 | 54 | M | Chemo | - | Remission | A*0201*2601B*3801*5101C*0701*1203 DRB1*1103*1301 DQB1*0301*0603 |
3. ACC-2805 | 58 | M | Chemo | - | Remission | A*01*02 B*08*44 C* 05*07 *03(17)*07 DQB1*02 |
4. ACC-2501 ACC-2065a | 57 | M | T, Chemo | Chemo | Persistent | A*0101*0301 B*4402 C* 0501 DRB1*0401*1501 DQB1*0301*0602 |
5. ACC-2781 | 66 | M | No treatment | - | Just diagnosis | A*01*31 B*08*40 (60) C*03*07 DRB1*03*04 DQB1*02*0302 |